Crocs, Inc. designs, manufactures, and distributes casual lifestyle footwear and accessories under the Crocs and HEYDUDE brands. The Colorado-based company is best known for its molded Croslite foam clogs and sandals, sold through wholesale, retail, and direct-to-consumer channels worldwide. The 2021 acquisition of HEYDUDE added a line of lightweight casual shoes aimed at everyday wear.
In the consumer discretionary footwear space, the company’s ability to maintain brand momentum, expand internationally, and execute on its product mix remains central to the investment case. A disciplined cost structure, ongoing share repurchases, and efforts to stabilize the HEYDUDE brand continue to draw attention from analysts and investors.
Over the trailing 30 days, CROX posted a clear upward move. Shares closed at $122.63 on September 29, 2026, and reached roughly $147.50 intraday on October 29, 2026, after the earnings release—a gain of about 20%.
The three-month view looks more mixed. Three months earlier the stock traded in the $128–$135 range and touched the low $140s in early August before pulling back. Ahead of the Q3 report, shares had eased to around $119.69, leaving the trailing quarter down on a mid-single-digit basis. The post-earnings jump reversed that trend, carrying the stock to fresh 52-week highs and leaving it up roughly 15% from late-July levels.
The primary driver was the third-quarter earnings release. Crocs posted revenue of $1.04 billion, up 4.6% year over year and ahead of the roughly $1.0 billion consensus. Adjusted diluted EPS reached $3.69, well above the $3.30–$3.31 expected and up 26.4% from $2.92 a year earlier. GAAP diluted EPS climbed 67.4% to $4.52.
Segment performance supported the positive tone. Crocs brand revenue rose 4.4% to $873 million, helped by double-digit international growth that offset softer North American results. HEYDUDE revenue increased 6.1% to $170 million, returning the brand to growth. Gross margin expanded to 66.2% from 58.5%, aided partly by one-time tariff refunds, and the company repurchased about 2.0 million shares for $250 million during the quarter.
Guidance reinforced the momentum. For Q4 2026, management called for revenue growth of 7%–9% and adjusted EPS of $3.25–$3.45, above the roughly $3.11 consensus. Full-year 2026 adjusted EPS guidance was lifted to $14.45–$14.65 from $13.70–$14.00, with full-year revenue growth raised to about 3%. Earlier in October, Barclays upgraded the stock to Overweight and lifted its price target to $139, providing an additional lift ahead of results.
Over the trailing three months, CROX reflected changing views on consumer demand, tariffs, and brand recovery. After trading near the low $140s in early August, the stock drifted lower through September and early October amid softer North American trends and a mixed discretionary backdrop. The Barclays upgrade on October 15 offered a brief lift, yet shares stayed range-bound in the $115–$125 area until the earnings report.
The Q3 results effectively reframed the earlier pullback. Evidence that HEYDUDE had stabilized, international growth remained strong, margins were expanding, and guidance had been raised—along with continued buybacks—shifted the narrative from consolidation to a fundamental inflection point.
Looking ahead, attention will center on whether Crocs can sustain fourth-quarter momentum, especially the HEYDUDE brand’s return to growth and continued double-digit international expansion. Full-year guidance now points to improved revenue and earnings, though North American demand stays in focus after recent softness. Tariff-related items and cost initiatives helped margins this quarter, so the durability of underlying profitability will be watched closely.
Additional analyst actions, institutional flows, and any updated price targets after the earnings re-rating will also matter, together with broader consumer-spending trends and macroeconomic conditions affecting discretionary footwear demand. I also checked this using Tickeron’s AI Screener to compare the stock with peers in the sector.
In my own research process, I turned to Tickeron’s AI Trading Bots to see how automated strategies have been positioned around names like CROX. The platform offers a range of bots with different timeframes and risk parameters, allowing me to review historical performance and current signals without relying on any single approach. This kind of data helps round out the fundamental picture with a quantitative lens.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
On October 29, 2026, the Stochastic Oscillator for CROX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In 45 of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over 78%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on CROX as a result. In 57 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for CROX just turned positive on October 15, 2026. Looking at past instances where CROX's MACD turned positive, the stock continued to rise in 29 of 45 cases over the following month. The odds of a continued upward trend are 64%.
CROX moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CROX crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +25.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where CROX advanced for three days, in 201 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CROX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
CROX broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 25 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CROX's P/B Ratio (5.203) is slightly higher than the industry average of (3.002). P/E Ratio (13.262) is within average values for comparable stocks, (12.557). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (0.949). CROX's Dividend Yield (0.067) is considerably higher than the industry average of (0.022). P/S Ratio (1.460) is also within normal values, averaging (1.252).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. CROX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CROX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a retailer of footwear for men, women and children
Industry WholesaleDistributors